News & AnalysisGencove grabs $10m Series AGencove, a low-pass genome sequencing platform company, has secured $10 million in Series A funding.ByIris Dorbian26 October 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs